39 studies found for:    "von Willebrand disease"
Show Display Options
Rank Status Study
21 Recruiting Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: plasma-derived FVIII/VWF concentrate Fanhdi
22 Completed Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Condition: Von Willebrand Disease
Intervention: Biological: Recombinant von Willebrand factor (rVWF) with or without rFVIII (Advate)
23 Completed The Von Willebrand Disease (VWD) International Prophylaxis Study
Condition: Von Willebrand Disease
Intervention: Drug: VWF/FVIII products
24 Completed Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease
Condition: Von Willebrand's Disease
Intervention: Drug: von Willebrand factor
25 Recruiting Willebrand International Non-interventional Global Surveillance
Condition: Von Willebrand Disease
Intervention:
26 Completed Efficacy and Safety of IL-11 in DDAVP Unresponsive
Conditions: Hemophilia A;   Von Willebrand Disease
Intervention: Biological: Neumega (Oprelvekin, Interleukin 11, IL-11)
27 Recruiting Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients
Condition: Von Willebrand Disease
Intervention: Biological: Alphanate SD/HT
28 Terminated Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle
Condition: Von Willebrand Disease
Intervention:
29 Active, not recruiting TYPE 3 VON WILLEBRAND INTERNATIONAL REGISTRIES INHIBITOR PROSPECTIVE STUDY
Condition: Type 3 Von Willebrand's Disease
Intervention:
30 Completed Acquired Von Willebrand Syndrome in Severe Aortic Stenosis
Conditions: Bleeding;   Von Willebrand Disease;   Aortic Stenosis
Intervention:
31 Completed A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)
Condition: Von Willebrand Disease
Intervention:
32 Completed Treatment and Management of Women With Bleeding Disorders
Conditions: Menorrhagia;   Blood Coagulation Disorders;   Blood Platelet Disorders;   Von Willebrand Disease;   Hematologic Disease
Interventions: Drug: Tranexamic Acid;   Drug: Desmopressin Acetate
33 Completed ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders
Conditions: Purpura, Thrombotic Thrombocytopenic;   Von Willebrand Disease Type-2b
Intervention: Drug: ARC1779
34 Completed The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders
Conditions: vonWillebrand Disease;   Hemophilia;   Platelet Coagulation Disorders
Intervention: Drug: Cyclokapron
35 Completed A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.
Condition: Von Willebrand Disease
Intervention: Biological: Optivate® (Human Coagulation Factor VIII)
36 Unknown  The Effect of the Nutraceutical "Hemofix" on the Coagulation System
Conditions: Von Willebrand Disease;   Menorrhagia
Intervention: Dietary Supplement: HEMOFIX
37 Unknown  Evaluation of Menses in Congenital Bleeding Disorders
Conditions: Von Willebrand Disease;   Congenital Coagulation Factors Deficiency;   Haemophilia Carriers
Intervention:
38 Completed
Has Results
Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery
Condition: Prevent Bleeding in Major Surgery
Intervention: Biological: human VWF/FVIII concentrate
39 Withdrawn Changes in Bleeding and Clotting During the Menstrual Cycle
Conditions: Von Willebrand's Disorder;   Healthy
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-39) Next Page   
Indicates status has not been verified in more than two years